Patients heterozygous for p52LOF/IκBδGOF alleles, the patients most frequently identified among those with AD NF-κB2 disorders, have PAD, viral diseases, pituitary endocrine defects, and/or ectodermal dysplasia (6, 13, , , –17). Here, NFKB2 is linked to Alzheimer disease.